17.4 Final Review & Key Points

Key Takeaways

  • MFDS Part 1 tests broad applied dental knowledge and clinical reasoning across six weighted domains; success comes from breadth plus depth in high-yield areas.
  • Rehearse the high-stakes, protocol-driven topics until automatic: medical emergencies (drugs and doses), LA toxicity, antibiotic stewardship, consent and capacity, safeguarding, and infection control.
  • Pair facts with their rationale — knowing why (the mechanism, the guideline basis) makes recall robust under exam pressure and supports reasoning on unfamiliar stems.
  • Use the exam-day technique: read the lead-in, predict, eliminate, flag and move on, answer every question — and trust preparation.
  • Passing Part 1 unlocks Part 2 (the 14-station OSCE); maintain the knowledge base as the foundation for clinical practice and the next stage of the MFDS pathway.
Last updated: August 2026

What MFDS Part 1 Tests

MFDS Part 1 examines whether a dentist at DCT level can apply a broad knowledge base to clinical scenarios. The exam is not rote recall — it rewards understanding and reasoning: choosing the best diagnosis, the most appropriate first action, the best investigation, and the safest prescribing decision. Across the six domains, recurring themes are patient safety, evidence-based choice, and the management of common conditions.

The Final-Review Checklist

Use this as a last-week review — tick each area and re-rehearse any weak topic.

Clinical Dentistry (40%)

  • Caries: diagnosis, critical pH (~5.5 enamel), prevention (fluoride, fissure sealants), management by lesion depth.
  • Operative dentistry: cavity design, materials choice, adhesive principles (hybrid layer, C-factor).
  • Endodontics: pulp/periradicular diagnosis, access, irrigation (NaOCl), obturation, the AAE 2009 classification of pulpal/apical disease.
  • Periodontology: plaque biofilm, periodontopathogens (red complex, A. actinomycetemcomitans), BPE, treatment staging, systemic links.
  • Prosthodontics: fixed (preparation, retention/resistance) and removable (support, retention, border seal).
  • Paediatric dentistry: behaviour management, caries management, trauma (IADT guidelines), stainless-steel crowns, the developing dentition.
  • Orthodontics: IOTN, interceptive treatment, anchorage.
  • Oral surgery: extraction indications/contraindications, third molar assessment, complications, implants.
  • Trauma: luxation, avulsion (immediate reimplantation, storage media), splinting durations.

Human Disease (20%)

  • Medical emergencies (automatic recall): anaphylaxis (IM adrenaline 0.5 mg), hypoglycaemia, syncope, seizures, chest pain (aspirin 300 mg), asthma (salbutamol).
  • Cardiovascular: hypertension, ischaemic heart disease, anticoagulation (INR, DOACs).
  • Respiratory: asthma, COPD.
  • Endocrine: diabetes (DKA/HHS), thyroid.
  • Haematology: anaemia, sickle cell, bleeding disorders, anticoagulants and dental management.
  • Infection: viral hepatitis, HIV, tuberculosis — relevance to dental management.
  • The medically compromised patient: modifying treatment for systemic disease.

Oral Pathology & Oral Medicine (15%)

  • White lesions: leukoplakia, lichen planus, candidiasis.
  • Vesiculobullous: pemphigus (acantholysis, Nikolsky), pemphigoid (subepithelial), erythema multiforme.
  • Ulcers: aphthous, traumatic, malignant — referral for an ulcer >3 weeks.
  • Cysts: radicular, dentigerous, odontogenic keratocyst (OKC), nasopalatine.
  • Tumours: ameloblastoma, odontoma, squamous cell carcinoma.
  • Salivary: obstruction (sialolith), mumps, Sjögren's, neoplasia (pleomorphic adenoma).
  • Orofacial pain: TMD, trigeminal neuralgia, atypical facial pain.

Pharmacology (10%)

  • LA: maximum doses (lidocaine 4.4 mg/kg, articaine 7 mg/kg), toxicity, methaemoglobinaemia (prilocaine), adrenaline contraindications.
  • Analgesia: paracetamol, NSAIDs (cautions — asthma, renal, GI, anticoagulation, lithium, pregnancy).
  • Sedation: nitrous oxide, midazolam (antagonist flumazenil), indications/contraindications.
  • Antimicrobials: first-line amoxicillin/metronidazole, stewardship (AWaRe), when NOT to prescribe, infective endocarditis prophylaxis (NICE — not recommended).
  • Interactions: warfarin + metronidazole/miconazole (avoid), macrolide + statin, NSAID + lithium, tetracycline chelation.

Materials, Microbiology, Radiology (10%)

  • Materials: amalgam phases (γ, γ₁, γ₂; high-Cu), composite (Bis-GMA, polymerisation shrinkage, bonding), GIC (chemical bond, fluoride), cements and impression materials (addition silicone vs polyether).
  • Microbiology: biofilm, S. mutans, periodontopathogens, infection control (standard precautions, DUWLs ≤100 CFU/mL, HTM 01-05, prions/endodontic files single-use).
  • Radiology: paralleling vs bisected-angle, selection criteria (ALARP/IRMER), panoramic/CBCT, technique errors (cone-cut, foreshortening, elongation).
  • Radiation protection: rectangular collimation, inverse square law, pregnancy, dose limits, IRR17/IRMER.

Law, Ethics, Professionalism & EBD (5%)

  • Consent: elements, MCA (best interests), Gillick, Montgomery (material risks).
  • Confidentiality: GDPR/Data Protection Act, public-interest disclosure.
  • GDC Standards, scope of practice, CPD, indemnity, fitness to practise.
  • Safeguarding: child abuse categories, head-and-neck signs, Care Act 2014 (adults), duty of candour (CQC Reg 20).
  • EBD and statistics: hierarchy of evidence, PICO, study designs, Type I/II errors and power, diagnostic test measures (sensitivity/specificity vs PPV/NPV), correlation vs causation, ITT analysis, GRADE.

How to Use the Final Week

  1. Re-rehearse protocol topics to automaticity — emergency drugs and doses, LA max doses, the warfarin prescribing algorithm.
  2. Drill the high-frequency lesion and pharmacology stems with quick-recall cards.
  3. Do timed practice questions in the final days to calibrate pace.
  4. Skim the checklist above and re-rehearse any ticked-but-weak area.
  5. Rest the day before — cramming fatigues and underperformance follows.

Pairing Facts with Rationale

Facts memorised without rationale are fragile. For each high-yield fact, know the why:

  • IM adrenaline for anaphylaxis because it reverses bronchospasm, vasodilation, and oedema.
  • No endocarditis prophylaxis because evidence does not support a causal link from dental procedures.
  • Metronidazole + warfarin is avoided because CYP2C9 inhibition raises INR.
  • A torn frenum in a non-mobile infant is concerning because non-mobile infants should not sustain such injuries.

Rationale makes recall robust and supports reasoning on stems you have not seen before.

The Pathway Forward

  • Pass MFDS Part 1 (new format: 180 SBA across 2 papers; modified Angoff pass mark).
  • MFDS Part 2 — the 14-station OSCE assessing clinical and communication skills across realistic scenarios.
  • DCT (Dental Core Training) — the COPDEND curriculum the exam maps to; DCT2/3 posts.
  • Further training — specialist training pathways, building on the knowledge base you have consolidated here.

The knowledge you have built for Part 1 is the foundation for safe, evidence-based clinical practice throughout your career. Review, rehearse, and approach the exam with confidence in the preparation you have done.

Test Your Knowledge

Which best summarises the rationale for rehearsing emergency-drug doses (e.g. IM adrenaline 0.5 mg for anaphylaxis) to automaticity before MFDS Part 1?

A
B
C
D
Test Your Knowledge

Which topic pairing correctly identifies two protocol-driven, high-frequency areas that MFDS Part 1 candidates should rehearse to automaticity?

A
B
C
D
Test Your Knowledge

After passing MFDS Part 1, what does the MFDS pathway require next?

A
B
C
D
Congratulations!

You've completed this section

Continue exploring other exams